Hongyu Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hongyu Peng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Changjiang Li
Beijing Anzhen Hospital, and Beijing Institute of Heart, Lung and Blood Vessel Diseases
2 shared publicationsShun Zhao
Beijing Anzhen Hospital, and Beijing Institute of Heart, Lung and Blood Vessel Diseases
2 shared publicationsYejing Zhao
Beijing Anzhen Hospital, and Beijing Institute of Heart, Lung and Blood Vessel Diseases
2 shared publicationsBaoyu Feng
Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1 shared publicationChenxi Xia
Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
1 shared publication- Hangyu Gong
Department of Cardiology, Dalian The Sixth People’s Hospital, Dalian, China
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1785441
Threshold effects of insulin resistance on cognitive function in coronary heart disease: the non-linear diagnostic value of the triglyceride-glucose index
Background: Insulin resistance contributes to cognitive dysfunction in patients with coronary heart disease (CHD). We examined the dose-response relationship between the triglyceride-glucose (TyG) index and cognitive status in this population. Methods: We analyzed data from 839 CHD patients, classifying cognitive function as Normal Cognition, Mild Cognitive Impairment, Severe Cognitive Impairment. Logistic regression and restricted cubic splines modeled the associations. We calculated net reclassification improvement (NRI) and integrated discrimination improvement (IDI) to test the predictive value of TyG beyond standard risk factors. Results: The severity of cognitive impairment increased with increasing TyG levels. In fully adjusted models, compared to the lowest tertile, the highest TyG tertile was associated with mild cognitive impairment (OR: 1.866, 95% CI: 1.268–2.748) and severe cognitive impairment (OR: 3.255, 95% CI: 1.870–5.668). Spline analysis showed a J-shaped curve for severe cognitive impairment ( P for non-linearity = 0.029) and a linear trend for mild cognitive impairment ( P for non-linearity = 0.619). Adding TyG to baseline models improved risk reclassification for severe cognitive impairment (NRI: 0.405, P < 0.001; IDI: 0.031, P = 0.023) and mild cognitive impairment (NRI: 0.185, P = 0.024). Conclusion: In patients with CHD, the TyG index identifies a specific metabolic threshold associated with severe cognitive impairment. The distinct non-linear trajectory and significant reclassification improvement suggest that the TyG index captures residual metabolic-inflammatory risk not addressed by traditional factors, highlighting its utility as a target for neuroprotective strategies.
- 14 April 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1785441
Open AccessThreshold effects of insulin resistance on cognitive function in coronary heart disease: the non-linear diagnostic value of the triglyceride-glucose index
Background: Insulin resistance contributes to cognitive dysfunction in patients with coronary heart disease (CHD). We examined the dose-response relationship between the triglyceride-glucose (TyG) index and cognitive status in this population. Methods: We analyzed data from 839 CHD patients, classifying cognitive function as Normal Cognition, Mild Cognitive Impairment, Severe Cognitive Impairment. Logistic regression and restricted cubic splines modeled the associations. We calculated net reclassification improvement (NRI) and integrated discrimination improvement (IDI) to test the predictive value of TyG beyond standard risk factors. Results: The severity of cognitive impairment increased with increasing TyG levels. In fully adjusted models, compared to the lowest tertile, the highest TyG tertile was associated with mild cognitive impairment (OR: 1.866, 95% CI: 1.268–2.748) and severe cognitive impairment (OR: 3.255, 95% CI: 1.870–5.668). Spline analysis showed a J-shaped curve for severe cognitive impairment ( P for non-linearity = 0.029) and a linear trend for mild cognitive impairment ( P for non-linearity = 0.619). Adding TyG to baseline models improved risk reclassification for severe cognitive impairment (NRI: 0.405, P < 0.001; IDI: 0.031, P = 0.023) and mild cognitive impairment (NRI: 0.185, P = 0.024). Conclusion: In patients with CHD, the TyG index identifies a specific metabolic threshold associated with severe cognitive impairment. The distinct non-linear trajectory and significant reclassification improvement suggest that the TyG index captures residual metabolic-inflammatory risk not addressed by traditional factors, highlighting its utility as a target for neuroprotective strategies.
- Open Access
- 11 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1653948
Triglyceride-glucose index as a novel prognostic biomarker for coronary artery disease: evidence from a large-scale prospective cohort study
Objective: The triglyceride-glucose (TyG) index, combining fasting glucose and triglyceride levels, has emerged as a promising biomarker for coronary artery disease (CAD). However, evidence for its long-term prognostic value in CAD remains limited and inconclusive.Methods: This prospective cohort study was conducted at Beijing Hospital between January 2016 and December 2021, involving 23,591 patients with CAD. Based on the inclusion and exclusion criteria, a total of 11,325 CAD patients were included in the final analysis. TyG index was determined using the formula ln [fasting triglycerides (mg/dL) × fasting glucose. Eligible participants were stratified by TyG tertiles: Tertile 1 (TyG ≤ 8.39, n=3,775); Tertile 2 (8.40 ≤ TyG ≤ 8.92, n=3,776); Tertile 3 (TyG ≥ 8.93, n=3,774), with a median follow-up duration of 28 months. The primary outcomes were all-cause death and cardiovascular disease (CVD) death. The secondary outcome was major adverse cardiovascular events (MACE). Cox proportional hazards models and restricted cubic spline (RCS) analysis were applied to investigate the relationship between the TyG index and endpoints.Results: RCS analyses showed a monotonic increase in all-cause death, CVD death, and MACE risks with higher TyG. Kaplan-Meier curves confirmed worse survival in higher TyG tertiles. Multivariable-adjusted analysis revealed continuous TyG index was an independent risk factor for all-cause death (HR = 1.22; 95% CI 1.02-1.45) and CVD death (HR = 1.61; 95% CI 1.17-2.22). Using the lowest TyG index tertile as the reference (T1), the highest tertile (T3) group exhibited a 1.34-fold risk of all-cause death (95% CI 1.04-1.72), a 1.99-fold risk of CVD death (95% CI 1.23-3.21), and a 1.17-fold higher risk of MACE (95% CI 1.00-1.37), respectively. Subgroup analyses showed the continuous TyG index was significantly associated with the risk of all-cause death in acute coronary syndrome (ACS) (HR = 1.33, 95% CI 1.01-1.74) and CVD death in chronic coronary syndrome (CCS) (HR = 1.79, 95% CI 1.16-2.78). With T1 as the reference, patients with CCS in the T3 group had a 2.15-fold higher risk of CVD death (95% CI 1.10-4.23).Conclusion: The TyG index correlates with increased all-cause death, CVD death, and MACE risks in CAD, with prognostic value in both ACS and CCS, particularly in CCS. These findings establish TyG as a robust CAD biomarker, warranting further clinical research.
- 11 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1653948
Open AccessTriglyceride-glucose index as a novel prognostic biomarker for coronary artery disease: evidence from a large-scale prospective cohort study
Objective: The triglyceride-glucose (TyG) index, combining fasting glucose and triglyceride levels, has emerged as a promising biomarker for coronary artery disease (CAD). However, evidence for its long-term prognostic value in CAD remains limited and inconclusive.Methods: This prospective cohort study was conducted at Beijing Hospital between January 2016 and December 2021, involving 23,591 patients with CAD. Based on the inclusion and exclusion criteria, a total of 11,325 CAD patients were included in the final analysis. TyG index was determined using the formula ln [fasting triglycerides (mg/dL) × fasting glucose. Eligible participants were stratified by TyG tertiles: Tertile 1 (TyG ≤ 8.39, n=3,775); Tertile 2 (8.40 ≤ TyG ≤ 8.92, n=3,776); Tertile 3 (TyG ≥ 8.93, n=3,774), with a median follow-up duration of 28 months. The primary outcomes were all-cause death and cardiovascular disease (CVD) death. The secondary outcome was major adverse cardiovascular events (MACE). Cox proportional hazards models and restricted cubic spline (RCS) analysis were applied to investigate the relationship between the TyG index and endpoints.Results: RCS analyses showed a monotonic increase in all-cause death, CVD death, and MACE risks with higher TyG. Kaplan-Meier curves confirmed worse survival in higher TyG tertiles. Multivariable-adjusted analysis revealed continuous TyG index was an independent risk factor for all-cause death (HR = 1.22; 95% CI 1.02-1.45) and CVD death (HR = 1.61; 95% CI 1.17-2.22). Using the lowest TyG index tertile as the reference (T1), the highest tertile (T3) group exhibited a 1.34-fold risk of all-cause death (95% CI 1.04-1.72), a 1.99-fold risk of CVD death (95% CI 1.23-3.21), and a 1.17-fold higher risk of MACE (95% CI 1.00-1.37), respectively. Subgroup analyses showed the continuous TyG index was significantly associated with the risk of all-cause death in acute coronary syndrome (ACS) (HR = 1.33, 95% CI 1.01-1.74) and CVD death in chronic coronary syndrome (CCS) (HR = 1.79, 95% CI 1.16-2.78). With T1 as the reference, patients with CCS in the T3 group had a 2.15-fold higher risk of CVD death (95% CI 1.10-4.23).Conclusion: The TyG index correlates with increased all-cause death, CVD death, and MACE risks in CAD, with prognostic value in both ACS and CCS, particularly in CCS. These findings establish TyG as a robust CAD biomarker, warranting further clinical research.
- Open Access
- 29 January 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-16
Triglyceride-glucose index predicts adverse cardiovascular events in patients with H-type hypertension combined with coronary heart disease: a retrospective cohort study
The triglyceride‒glucose index (TyG index) is a reliable surrogate for insulin resistance (IR) in individuals with type 2 diabetes mellitus and is associated with cardiovascular disease. Recent studies have reported that H-type hypertension is likewise a predictor of adverse events in patients with coronary heart disease (CHD). However, the relationship between the TyG index and prognosis in patients with H-type hypertension combined with CHD has not yet been reported. In this study, we investigated the relationship between the TyG index and adverse outcomes in patients with H-type hypertension combined with CHD. This was a single-center retrospective cohort study that included patients who were diagnosed with H-type hypertension combined with CHD between 2018 and 2023 at Beijing Anzhen Hospital of Capital Medical University. The TyG index was divided into three groups according to tertiles. Kaplan–Meier curves were used to analyze the cumulative risk of major adverse cardiovascular events (MACEs), and ROC curve analysis was performed by the log-rank test. Cox proportional hazards regression models were adopted to explore the relationship between the TyG index and MACEs. C-statistics, NRI, and IDI were used to evaluate the incremental predictive ability of the TyG index. A total of 546 patients were included, with a median follow-up time of 39.00 ± 0.69 months, and 73 MACEs occurred, with higher tertiles of the TyG index associated with a higher cumulative risk of MACEs (log-rank, P = 0.001). After adjusting for confounders, the fully adjusted ORs (95% CI) for T2 and T3 of the TyG index, with the lowest tertile as reference, were 1.64 (0.80–3.36) and 2.43 (1.19–4.97), respectively. The addition of the TyG index led to a significant improvement in the overall predictive power of the baseline model. [C-statistic increased from 0.63 to 0.66, p = 0.031; continuous NRI (95% CI) 0.13 (0.001–0.276), p = 0.038; IDI (95% CI) 0.01 (0.000–0.031), p = 0.047]. The TyG index may be an independent risk factor for predicting adverse postoperative cardiovascular events in patients with H-type hypertension combined with CHD, indicating its potential significance in improving risk stratification strategies.
- 29 January 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-16
Open AccessTriglyceride-glucose index predicts adverse cardiovascular events in patients with H-type hypertension combined with coronary heart disease: a retrospective cohort study
The triglyceride‒glucose index (TyG index) is a reliable surrogate for insulin resistance (IR) in individuals with type 2 diabetes mellitus and is associated with cardiovascular disease. Recent studies have reported that H-type hypertension is likewise a predictor of adverse events in patients with coronary heart disease (CHD). However, the relationship between the TyG index and prognosis in patients with H-type hypertension combined with CHD has not yet been reported. In this study, we investigated the relationship between the TyG index and adverse outcomes in patients with H-type hypertension combined with CHD. This was a single-center retrospective cohort study that included patients who were diagnosed with H-type hypertension combined with CHD between 2018 and 2023 at Beijing Anzhen Hospital of Capital Medical University. The TyG index was divided into three groups according to tertiles. Kaplan–Meier curves were used to analyze the cumulative risk of major adverse cardiovascular events (MACEs), and ROC curve analysis was performed by the log-rank test. Cox proportional hazards regression models were adopted to explore the relationship between the TyG index and MACEs. C-statistics, NRI, and IDI were used to evaluate the incremental predictive ability of the TyG index. A total of 546 patients were included, with a median follow-up time of 39.00 ± 0.69 months, and 73 MACEs occurred, with higher tertiles of the TyG index associated with a higher cumulative risk of MACEs (log-rank, P = 0.001). After adjusting for confounders, the fully adjusted ORs (95% CI) for T2 and T3 of the TyG index, with the lowest tertile as reference, were 1.64 (0.80–3.36) and 2.43 (1.19–4.97), respectively. The addition of the TyG index led to a significant improvement in the overall predictive power of the baseline model. [C-statistic increased from 0.63 to 0.66, p = 0.031; continuous NRI (95% CI) 0.13 (0.001–0.276), p = 0.038; IDI (95% CI) 0.01 (0.000–0.031), p = 0.047]. The TyG index may be an independent risk factor for predicting adverse postoperative cardiovascular events in patients with H-type hypertension combined with CHD, indicating its potential significance in improving risk stratification strategies.
- 6 January 2021
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 14 (4) , 598-609
Angiographic Scoring System for Predicting Successful Percutaneous Coronary Intervention of In-Stent Chronic Total Occlusion
The purpose of this study was to develop a scoring model to predict the technical success of recanalizing via antegrade approach in-stent chronic total occlusion (IS-CTO) by percutaneous coronary intervention (PCI). We retrospectively collected data from 474 patients who underwent an uneasy IS-CTO PCI via antegrade approach from January 2015 to December 2018, consecutively. We selected clinical and angiographic factors and utilized a derivation and validation cohort (4:1 sampling ratio) analysis. Factors with strong correlations with technical failure, according to multivariable analysis, were assigned 1 point, and a scoring system with a 4-point maximum was established. The model was then validated with a validation cohort. The overall procedural success rate was 77.4%. On multivariable analysis, the factors that correlated with technical failure were proximal bending (beta coefficient [β] = 2.142), tortuosity (β = 2.622), stent under expansion (β = 3.052), and poor distal landing zone (β = 2.004). The IS-CTO score demonstrated good calibration and excellent predicting capacity in the derivation (receiver-operator characteristic [ROC] area = 0.973 and Hosmer-Lemeshow chi-squared = 5.252; p = 0.072) and validation (ROC area = 0.976 and Hosmer-Lemeshow chi-squared = 0.916; p = 0.632) cohorts. In the validation subset, the IS-CTO score demonstrated superior performance to the Japanese chronic total occlusion score (J-CTO) and PROGRESS CTO scores for predicting technical success (area under the a curve [AUC] 0.976 vs. 0.642 vs. 0.579, respectively; difference in AUC between the IS-CTO score and J-CTO score = 0.334, p < 0.01; difference in AUC between the IS-CTO score and PROGRESS score = 0.397, p < 0.01). Our results suggest that the IS-CTO score system is a helpful tool to predict the technical success of IS-CTO PCI via antegrade approach in china. Graphical Abstract
- 6 January 2021
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 14 (4) , 598-609
Angiographic Scoring System for Predicting Successful Percutaneous Coronary Intervention of In-Stent Chronic Total Occlusion
The purpose of this study was to develop a scoring model to predict the technical success of recanalizing via antegrade approach in-stent chronic total occlusion (IS-CTO) by percutaneous coronary intervention (PCI). We retrospectively collected data from 474 patients who underwent an uneasy IS-CTO PCI via antegrade approach from January 2015 to December 2018, consecutively. We selected clinical and angiographic factors and utilized a derivation and validation cohort (4:1 sampling ratio) analysis. Factors with strong correlations with technical failure, according to multivariable analysis, were assigned 1 point, and a scoring system with a 4-point maximum was established. The model was then validated with a validation cohort. The overall procedural success rate was 77.4%. On multivariable analysis, the factors that correlated with technical failure were proximal bending (beta coefficient [β] = 2.142), tortuosity (β = 2.622), stent under expansion (β = 3.052), and poor distal landing zone (β = 2.004). The IS-CTO score demonstrated good calibration and excellent predicting capacity in the derivation (receiver-operator characteristic [ROC] area = 0.973 and Hosmer-Lemeshow chi-squared = 5.252; p = 0.072) and validation (ROC area = 0.976 and Hosmer-Lemeshow chi-squared = 0.916; p = 0.632) cohorts. In the validation subset, the IS-CTO score demonstrated superior performance to the Japanese chronic total occlusion score (J-CTO) and PROGRESS CTO scores for predicting technical success (area under the a curve [AUC] 0.976 vs. 0.642 vs. 0.579, respectively; difference in AUC between the IS-CTO score and J-CTO score = 0.334, p < 0.01; difference in AUC between the IS-CTO score and PROGRESS score = 0.397, p < 0.01). Our results suggest that the IS-CTO score system is a helpful tool to predict the technical success of IS-CTO PCI via antegrade approach in china. Graphical Abstract